作者: Neal Hermanowicz , Gustavo Alva , Fernando Pagan , Alberto J. Espay , Amita Patel
DOI: 10.18553/JMCP.2017.23.6-B.S2
关键词: Nursing 、 MEDLINE 、 Quality of life (healthcare) 、 Disease management (health) 、 Pimavanserin 、 Patient education 、 Medicine 、 Geriatrics 、 Pharmacy 、 Disease
摘要: A panel of experts drawn from neurology, psychiatry, geropsychiatry, geriatrics, and pharmacy representatives 3 health plans convened in New York City on July 30, 2016, with the objective sharing opinions, ideas, information regarding optimal management Parkinson’s disease psychosis (PDP). Three key points emerged discussion: (1) Because nature PDP, finding appropriate treatment can prove challenging; (2) emerging therapies may present an opportunity for effective management; (3) moving forward, provider patient education PDP available options is essential well-managed symptoms better quality life. The reviewed current practices formulated recommendations forward PDP. DISCLOSURES: This project manuscript was funded by ACADIA Pharmaceuticals developed Magellan Rx Management. Lopes Farnum are employees Kremens has rec...